These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 34753385)
1. Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency. Cao Y; Chen Y; Wang P; Lu J; Han X; She J Bioengineered; 2021 Dec; 12(2):10345-10362. PubMed ID: 34753385 [TBL] [Abstract][Full Text] [Related]
2. Network pharmacology and transcriptomics analysis reveal the mechanism of BushenHuoxue formula attenuates premature ovarian failure via modulation PI3K/AKT pathway. Zhao W; Chen Y; He J; Chen S; Shen J; Jiao B; Li T; Su M; Mao T; Wang P Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):226-232. PubMed ID: 38814209 [TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic drug targets and pathways prediction for premature ovarian insufficiency -Based on network pharmacologic method. Ju S; He J; Wang H; Yang L; Guo A; Guo Y; Qi M; Wang H; Ai L J Ethnopharmacol; 2023 Mar; 304():116054. PubMed ID: 36526095 [TBL] [Abstract][Full Text] [Related]
4. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation. Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the Bushen Huoxue formula in the treatment of osteoarthritis based on network pharmacology-molecular targets. Pang T; Liu C; Yao J; Li J; Li Z; Lou H; Lei S; Zhang J; Dong L; Wang Y Medicine (Baltimore); 2022 Aug; 101(32):e29345. PubMed ID: 35960090 [TBL] [Abstract][Full Text] [Related]
6. Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of BanXia-YiYiRen in treating insomnia. Wang L; Wang P; Chen Y; Li C; Wang X; Zhang Y; Li S; Yang M Bioengineered; 2022 Feb; 13(2):3148-3170. PubMed ID: 35067174 [TBL] [Abstract][Full Text] [Related]
7. Network Pharmacology, Molecular Docking and Experimental Verification Revealing the Mechanism of Fule Cream against Childhood Atopic Dermatitis. Liu C; Liu Y; Liu Y; Guan J; Gao Y; Ou L; Qi Y; Lv X; Zhang J Curr Comput Aided Drug Des; 2024; 20(6):860-875. PubMed ID: 37807411 [TBL] [Abstract][Full Text] [Related]
8. The Network Pharmacology Analysis of Tonifying Yang Formula for the Treatment of Diminished Ovarian Reserve. Ma Q; Wu X; Chen D; Li W; Wu J; Shen M; Ye C; Tan Y; Guo Q Altern Ther Health Med; 2024 Mar; 30(3):176-184. PubMed ID: 37883761 [TBL] [Abstract][Full Text] [Related]
9. Network pharmacology analysis and molecular docking using the Chinese herbal agent WYHX formula (according to Yan Dexin): Management of coronary artery disease. Wang ZY; Zhou M; Sun YN; Hu XZ Int J Clin Pharmacol Ther; 2024 Aug; 62(8):363-376. PubMed ID: 38916485 [TBL] [Abstract][Full Text] [Related]
10. Potential active compounds and molecular mechanism of Xuefu Zhuyu decoction for atherosclerosis, based on network pharmacology and molecular docking. Li Y; Liu B; Liu L; Xu Q; Shen Q; Li W; Zhao J Medicine (Baltimore); 2022 Aug; 101(32):e29654. PubMed ID: 35960089 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of Bushen Huoxue granules in treatment of premature ovarian insufficiency: study protocol for a randomized, double-blinded, placebo-controlled, and multicenter clinical trial. Cao Y; Peijuan-Wang ; Lu Y; Chen Y; Chen S; Weibo-Zhao Trials; 2021 Dec; 22(1):877. PubMed ID: 34863269 [TBL] [Abstract][Full Text] [Related]
12. Exploring the mechanism of action of Yiyi Fuzi Baijiang powder in colorectal cancer based on network pharmacology and molecular docking studies. Yan H; Li Y; Yang B; Long F; Yang Z; Tang D Biotechnol Genet Eng Rev; 2023 Oct; 39(2):1107-1127. PubMed ID: 36735641 [TBL] [Abstract][Full Text] [Related]
13. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking. Wu Z; Ji X; Shan C; Song J; Zhao J Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443 [TBL] [Abstract][Full Text] [Related]
14. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke. Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367 [TBL] [Abstract][Full Text] [Related]
15. Exploration of potential targets and mechanisms of Naringenin in treating autism spectrum disorder via network pharmacology and molecular docking. Gai J; Xing J; Wang Y; Lei J; Zhang C; Zhang J; Tang J Medicine (Baltimore); 2022 Nov; 101(46):e31787. PubMed ID: 36401485 [TBL] [Abstract][Full Text] [Related]
16. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking. Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376 [TBL] [Abstract][Full Text] [Related]
17. Unraveling the Mechanism of Zhibaidihuang Decoction against IgA Nephropathy Using Network Pharmacology and Molecular Docking Analyses. Deng X; Luo Y; Lu M; Guan T; Li Y; Guo X Tohoku J Exp Med; 2022 Dec; 259(1):37-47. PubMed ID: 36288951 [TBL] [Abstract][Full Text] [Related]
18. Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology. He D; Li Q; Du G; Sun J; Meng G; Chen S Biomed Res Int; 2021; 2021():8141075. PubMed ID: 34873575 [TBL] [Abstract][Full Text] [Related]
19. The mechanism of Gejie Zhilao Pill in treating tuberculosis based on network pharmacology and molecular docking verification. Gao Y; Shang B; He Y; Deng W; Wang L; Sui S Front Cell Infect Microbiol; 2024; 14():1405627. PubMed ID: 39015338 [TBL] [Abstract][Full Text] [Related]
20. Network pharmacology and experimental validation to explore the role and potential mechanism of Liuwei Dihuang Decoction in prostate cancer. Zhan X; Li H; Jin J; Ju X; Gao J; Chen X; Yuan F; Gu J; Xu D; Ju G BMC Complement Med Ther; 2024 Jul; 24(1):284. PubMed ID: 39061044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]